Target intelligence / Profile preview

Unknown or non-specific molecular targets

Molecular classification
Other
01

Overview

Unknown or non-specific molecular targets is a classification used in pharmacological databases such as ChEMBL and DrugBank to describe drugs that lack a defined proteinaceous target (DrugBank, 2024). This category often includes agents that exert therapeutic effects through non-specific physical or chemical interactions, such as the neutralization of gastric acid by antacids or the creation of osmotic gradients by saline laxatives (StatPearls, 2023). Additionally, it serves as a placeholder for compounds where the clinical efficacy is established, but the specific molecular site of action has not yet been identified through experimental research (ChEMBL, 2024). Because these drugs do not bind to a specific receptor or enzyme, they often lack the high selectivity seen in modern targeted therapies, which can lead to broad physiological impacts (PubMed, 2021). Consequently, these agents present unique challenges in drug development and safety monitoring due to the difficulty in defining precise structure-activity relationships (NIH, 2022).

Other names
Non-specific mechanism of actionUnidentified molecular targetNon-target mediated actionPhysicochemical mechanism
02

Mechanism of action

Drugs in this category act via non-specific chemical or physical processes, such as neutralization of gastric acid, osmotic effects in the intestine, or non-specific perturbation of lipid membranes, or their specific protein targets have not yet been identified.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Lack of therapeutic selectivityPotential for broad off-target interactionsDifficulty in monitoring pharmacodynamicsElectrolyte imbalances (for osmotic/chemical agents)
06

Interacting drugs

Magnesium hydroxide

4 more in the full profile.

Beyond the preview

Go deeper on Unknown or non-specific molecular targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unknown or non-specific molecular targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call